This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 693
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
'''6-Mercaptopurine activity and targeting''' <br> | '''6-Mercaptopurine activity and targeting''' <br> | ||
| - | [[Image:Mercaptopurine.png]] | ||
| - | <Structure load='1hmp' size='500' frame='true' align='right' caption='GMP bound to HGPRT' scene='Insert optional scene name here' /> | + | <Structure load='1hmp' size='500' frame='true' align='right' caption='GMP bound to HGPRT' scene='Insert optional scene name here' /> |
| + | [[Image:Mercaptopurine.png]] | ||
6-Mercaptopurine (6-MP) is an anti-cancer drug used for decades to treat acute lymphoblastic leukemia, and in recent years for other conditions such as inflammatory bowel disease. | 6-Mercaptopurine (6-MP) is an anti-cancer drug used for decades to treat acute lymphoblastic leukemia, and in recent years for other conditions such as inflammatory bowel disease. | ||
Revision as of 21:17, 28 April 2013
| This Sandbox is Reserved from 30/01/2013, through 30/12/2013 for use in the course "Biochemistry II" taught by Hannah Tims at the Messiah College. This reservation includes Sandbox Reserved 686 through Sandbox Reserved 700. |
To get started:
More help: Help:Editing |
6-Mercaptopurine activity and targeting
|
6-Mercaptopurine (6-MP) is an anti-cancer drug used for decades to treat acute lymphoblastic leukemia, and in recent years for other conditions such as inflammatory bowel disease.
3ns1 - 6mp bound to bovine xanthine oxidase 2bzg - TPMT
